Health Canada authorizes long-awaited drug to slow early-stage Alzheimer’s disease
Health Canada authorizes long-awaited drug to slow early-stage Alzheimer’s disease
TORONTO — Health Canada has authorized a drug shown to slow the progression of Alzheimer's disease.
Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is believed to be
